These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18729286)

  • 21. Novel human pathological mutations. Gene symbol: DMD. Disease: muscular dystrophy, Duchenne.
    Garcia-Planells J; Torres-Puente M; Vilchez JJ; Pérez-Alonso M
    Hum Genet; 2009 Aug; 126(2):338. PubMed ID: 19694016
    [No Abstract]   [Full Text] [Related]  

  • 22. Aminoglycoside antibiotics: old drugs and new therapeutic approaches.
    Hermann T
    Cell Mol Life Sci; 2007 Jul; 64(14):1841-52. PubMed ID: 17447006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem-cell biology: a move in the right direction.
    Chamberlain JS
    Nature; 2006 Nov; 444(7119):552-3. PubMed ID: 17108968
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel human pathological mutations. Gene symbol: DMD. Disease: muscular dystrophy, Duchenne.
    Garcia-Planells J; Torres-Puente M; Vilchez JJ; Perez-Alonso M
    Hum Genet; 2009 Aug; 126(2):338. PubMed ID: 19694014
    [No Abstract]   [Full Text] [Related]  

  • 25. [Modern methods in the treatment of cystic fibrosis].
    Bush A
    Pediatr Pol; 1996 Jun; 71(6):566-72. PubMed ID: 8756778
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene symbol: DMD. Disease: Muscular dystrophy, Duchenne.
    Dasouki M; Barohn R
    Hum Genet; 2008 Oct; 124(3):321. PubMed ID: 18846679
    [No Abstract]   [Full Text] [Related]  

  • 27. Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy.
    Moulton HM; Wu B; Jearawiriyapaisarn N; Sazani P; Lu QL; Kole R
    Ann N Y Acad Sci; 2009 Sep; 1175():55-60. PubMed ID: 19796077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion.
    Ferreiro V; Giliberto F; Muñiz GM; Francipane L; Marzese DM; Mampel A; Roqué M; Frechtel GD; Szijan I
    Muscle Nerve; 2009 Feb; 39(2):239-43. PubMed ID: 19012301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.
    Aartsma-Rus A; Fokkema I; Verschuuren J; Ginjaar I; van Deutekom J; van Ommen GJ; den Dunnen JT
    Hum Mutat; 2009 Mar; 30(3):293-9. PubMed ID: 19156838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dystrophin gene analysis in Hungarian Duchenne/Becker muscular dystrophy families - detection of carrier status in symptomatic and asymptomatic female relatives.
    Pikó H; Vancsó V; Nagy B; Bán Z; Herczegfalvi A; Karcagi V
    Neuromuscul Disord; 2009 Feb; 19(2):108-12. PubMed ID: 19084397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation in dystrophin-encoding gene affects energy metabolism in mouse myoblasts.
    Onopiuk M; Brutkowski W; Wierzbicka K; Wojciechowska S; Szczepanowska J; Fronk J; Lochmüller H; Górecki DC; Zabłocki K
    Biochem Biophys Res Commun; 2009 Aug; 386(3):463-6. PubMed ID: 19527684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisense oligonucleotides in the treatment of Duchenne muscular dystrophy: Where are we now?
    Wilton SD; Fletcher S
    Neuromuscul Disord; 2005 Jun; 15(6):399-402. PubMed ID: 15907285
    [No Abstract]   [Full Text] [Related]  

  • 35. High incidence of electrocardiogram abnormalities in young patients with duchenne muscular dystrophy.
    Takami Y; Takeshima Y; Awano H; Okizuka Y; Yagi M; Matsuo M
    Pediatr Neurol; 2008 Dec; 39(6):399-403. PubMed ID: 19027585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
    Baskin B; Banwell B; Khater RA; Hawkins C; Ray PN
    Neuromuscul Disord; 2009 Mar; 19(3):189-92. PubMed ID: 19230662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis.
    Aitken ML
    Curr Opin Pulm Med; 1996 Nov; 2(6):435-8. PubMed ID: 9363181
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
    Heemskerk HA; de Winter CL; de Kimpe SJ; van Kuik-Romeijn P; Heuvelmans N; Platenburg GJ; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
    J Gene Med; 2009 Mar; 11(3):257-66. PubMed ID: 19140108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manifesting carriage of a Duchenne muscular dystrophy mutation: an unusual cause of impaired lung function in CF.
    Walker W; Connett G
    J R Soc Med; 2010 Jul; 103 Suppl 1(Suppl 1):S27-9. PubMed ID: 20573666
    [No Abstract]   [Full Text] [Related]  

  • 40. Baby steps towards gene therapy for humans.
    Marron K
    Lab Anim (NY); 2008 Nov; 37(11):484. PubMed ID: 18948980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.